Compounds Screening/Testing TRIZ Cases

A DNA vector encoding an infectious RNA molecule initiates live attenuated chikungunya virus production in host tissues.

Indicator fluids trace molecular movement within the cranio-spinal cavity to quantify substance clearance rates.

A water-soluble 18F-labeled prosthetic group enables rapid bioorthogonal click reactions for biomolecule labeling under mild aqueous conditions.

Fluorescent probe clearance measurement replaces invasive urine collection, resolving the trade-off between GFR accuracy and treatment timing delays in CRRT.

Segmented human coding exons replace mouse sequences to align RNA expression levels with human physiology, resolving low similarity bottlenecks.

Replacing invasive biopsies, this agent enables noninvasive detection of secondary mutations and monitoring of treatment resistance.

Immature seed extracts induce desensitization via protein denaturation, reducing adverse reactions and wheal size in allergic children.

Administering an Nrf2-activator to identify ASD phenotype 1 patients based on negative symptom response.

A brine shrimp ecotoxicity testing method uses second-instar larvae to evaluate disinfection by-products through acute and chronic exposure phases.

Genetically modified vertebrates express light-activatable proteins to trigger hormone release along the hypothalamic-pituitary-adrenal axis.

Isotopic amino acid tracers cross the blood-brain barrier to label central nervous system proteins for mass spectrometry detection.

A saccharide and acid composition induces animal models simulating human disease states.

Ultrasonic nebulization creates stable allergen aerosols, eliminating fan-induced particle degradation and concentration gradients.

Specific antibodies bind alpha-synuclein protofibrils to reduce toxic aggregates, addressing inadequate early-stage detection and symptomatic-only treatments.

Finazine compounds switch zebrafish freezing to escape behavior for rapid antipsychotic screening.

Heterogeneous nuclear ribonucleoprotein A2B1 binds viral DNA in the nucleus to initiate immune signaling pathways.

Transgenic models identify compounds reducing SRF levels to prevent diastolic dysfunction.

A transdermal skin patch containing recombinant SARS-CoV-2 antigens evokes local inflammation to detect cellular immune responses.

Molecular renal probes resolve low serum creatinine sensitivity by detecting early biomarkers before timing delays occur.

Intravenous lentiviral injection enables stable in vivo CRISPR screening, resolving delivery bottlenecks to reveal essential genes and sex-specific regulations.

A sialidase fusion protein anchors to respiratory epithelium to break down mucus.

Subcutaneous administration creates an antibody reservoir that extends half-life, enabling accurate prediction of human clinical outcomes.

A selective 5-HT2C receptor agonist reduces body weight by suppressing food intake.

Recombinant DNA constructs with tissue-specific promoters enable precise measurement of thyroid hormone action while avoiding unwanted cardiac side effects.

Light-responsive opsin proteins selectively alter neural membrane potential to control pelvic floor muscle activity.

Amide and ester conjugates link near infrared dyes to cisplatin, overcoming cellular resistance mechanisms.

Multi-biomarker panels resolve the trade-off between measurement precision and system complexity, enabling accurate discrimination of irradiated individuals.

Stepped tanks in a microfluidic device position zebrafish larvae via fluid flow, eliminating manual handling and anesthetic bias during drug screening.

Continuous electronic scale monitoring tracks meal frequency and duration, eliminating tolerance development from intermittent dosing cycles.

Replacing murine FcγR genes with human variants resolves the complexity of multi-gene co-expression while maintaining functional receptor signaling.

Engineering non-human animals with humanized Lag-3 genes creates in vivo models that assess therapeutic efficacy while avoiding direct human experimentation.

A transgenic mouse model uses a p16 promoter to drive cytotoxic enzyme expression in senescent cells.

Platform generates monoclonal antibodies binding processed Trop-2 forms, reducing on-target toxicity against normal tissues while maintaining antitumor potency.

GPR84 antagonists block neutrophil chemotaxis to treat inflammatory conditions lacking specific pathway inhibition.

Albumin stabilizes chlorin e6 against degradation, maintaining over 65% content for 12 months at room temperature.

Ethanol and polyether solubilize lipophilic stilbene, reducing adsorption losses during sterile filtration.

Modified mice express human APP and reduced iNOS function to generate robust amyloid plaques and neurofibrillary tangles.

Specific intestinal bacteria restore normal growth in malnourished juveniles by enhancing nutrient absorption and skeletal development.

Segmented ANO1 knockout in medial habenula cholinergic neurons creates a precise animal model for therapeutic agent screening.

Engineered induced dendritic cells express specific cytokines and antigens to drive self-differentiation and functional maturation.

A tunable monochromatic x-ray source exploits nuclear resonant absorption of iodine-127 to determine blood velocity.

Protocatechuic acid solutions treat resistant eye infections without drug toxicity or hypersensitivity risks.

Segmented compounds with vimentin-binding peptides deliver chemotherapeutic agents directly to cancer cells, reducing systemic toxicity to normal tissues.

Engineered T cells express a ligand binding domain to capture radiolabeled tracers, resolving background uptake issues in cell tracking.

Partial Epo gene knockout enables spontaneous anemia research without embryonic lethality.

A rodent model manipulates dorsal root entry zone fibers to generate aberrant spinal cord activity while preserving motor and sensory functions.

ROSA KIT WT cell line overcomes poor reproducibility in primary mast cell isolation to provide a stable, cost-effective model for allergy drug discovery.

Water-soluble anthracenyl-tetralactam macrocycles bind glucose via non-covalent interactions to enable continuous in vivo monitoring.